Sant Quirze del Vallès, Spain

Xavier Formosa Márquez

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xavier Formosa Márquez. Retrieved from https://idiyas.com/inventor/xavier-formosa-márquez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xavier Formosa Márquez and Sodium-Free Effervescent Pharmaceutical Compositions

Introduction

Xavier Formosa Márquez is an inventor associated with Sant Quirze del Vallès, Spain. His patent work includes a pharmaceutical formulation designed to provide effervescence while keeping sodium content very low.

Latest Patents

Formosa Márquez is associated with 1 patent: “Essentially Sodium-Free Effervescent Solid Pharmaceutical Compositions.” The invention describes a solid pharmaceutical composition containing an active pharmaceutical ingredient, alkaline earth metal carbonates or hydrogencarbonates, and pharmaceutically acceptable acids or acid salts. It specifies that the composition’s total sodium-ion content is no more than 1 mmol. The patent also addresses preparation processes and therapeutic use.

Career Highlights

Formosa Márquez is associated with Intas Pharmaceuticals Limited. His patent reflects work on pharmaceutical formulation, particularly the development of effervescent compositions with substantially reduced sodium content.

Collaborations

The listed coworkers associated with Formosa Márquez are José María Suñé Negre and Anna Nardi Ricart.

Conclusion

Xavier Formosa Márquez’s patent focuses on an essentially sodium-free effervescent pharmaceutical composition, alongside methods for preparing and using it in therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…